Join
Live feed
·
PRReleasevia Quantisnow
Liquidia Corporation logo

FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis

ByQuantisnow·Wall Street's wire, on your screen.
LQDA· Liquidia Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LQDA (Liquidia Corporation) and more on Quantisnow.